Multiple Myeloma

A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.

Also Known As:

Kahler Disease; Myeloma, Multiple; Myeloma-Multiple; Myelomatosis; Plasma Cell Myeloma; Cell Myeloma, Plasma; Cell Myelomas, Plasma; Disease, Kahler; Multiple Myelomas; Myeloma Multiple; Myeloma, Plasma Cell; Myeloma-Multiples; Myelomas, Multiple; Myelomas, Plasma Cell; Myelomas, Plasma-Cell; Myelomatoses; Plasma Cell Myelomas; Plasma-Cell Myeloma; Plasma-Cell Myelomas; Myeloma, Plasma-Cell

Neoplasms: 1361496
- Neoplasms by Histologic Type: 2
  - Plasma Cell Neoplasms: 237
    - Multiple Myeloma: 27244
Cardiovascular Diseases: 94258
- Vascular Diseases: 15340
  - Hemostatic Disorders: 256
    - Multiple Myeloma: 27244
Hemic and Lymphatic Diseases: 7
- Hematologic Diseases: 3445
  - Hemorrhagic Disorders: 706
    - Hemostatic Disorders: 256
      - Multiple Myeloma: 27244
  - Blood Protein Disorders: 17
    - Paraproteinemias: 3515
      - Multiple Myeloma: 27244
Immune System Diseases: 4430
- Immunoproliferative Disorders: 29
  - Lymphoproliferative Disorders: 4321
    - Multiple Myeloma: 27244
  - Paraproteinemias: 3515
    - Multiple Myeloma: 27244

Inter-Groupe Francophone du Myélome (IFM) Selected Research

Inter-Groupe Francophone du Myélome (IFM) Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure